Stryker: Here’s What Investors Need to Know Before Earnings
Stryker (NYSE:SYK) will report earnings after markets close on Thursday, July 18th. Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment.
Here is your Cheat Sheet to Stryker Earnings:
Earnings Expectations: Analysts expect earnings of $1.03 per share on revenues of $2.19 billion. Currently, the company’s P/E ratio stands at 20.61.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.03 to a profit $1.01. For the current year, the average estimate is a profit of $4.29, which is worse than the estimate ninety days ago.
Here’s how Stryker has been performing on an annual basis:
|Revenue ($) in millions||6,718||6,723||7,320||8,307||8,657|
|Diluted EPS ($)||2.78||2.77||3.19||3.45||3.39|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||2,106.00||2,052.00||2,337.00||2,190.00|
|Diluted EPS ($)||0.85||0.92||0.71||0.79|
Stryker has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)